Nice | Familial breast cancer

18th July 2013 by Louise Hudman

This familial breast cancer guideline doesn’t change anything for us. Our role is to risk assess women and refer on to the genetics services if they may be at high risk. NICE do say that this shouldn’t be screening, but a response to a concerned woman, or if there seems to be a significant history on doing a pill or HRT check.

Also of interest is that ‘TP53’ is now tested for, alongside BRCA1 and 2

How to do a familial breast cancer risk assessment

This hasn’t changed from the last guideline. There was a handy flowchart in the last guideline, which I keep printed out to use.

Combined oral contraceptive (COC) use

Join

Join to view the rest of this content, as well as access all the benefits of joining NASGP.

Join

Login

Already a member? Login to view this content.

Login

"I started working as a locum GP in January this year and NASGP have been invaluable in helping to co-ordinate my bookings and organise all the administrative aspects of sessional work which can be complex and time consuming. Their client support is outstanding and they have always resolved any queries promptly and personally. They care about the service they provide and I would not hesitate to recommend them to any sessional GPs who want to minimise time spent on administration and focus on providing patients with high quality care."

Dr Paul Riley, Locum GP

Dr Paul Riley, Locum GP

See the full list of features within our NASGP membership plans

Membership